Filing Details
- Accession Number:
- 0001179110-19-005053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-16 21:28:56
- Reporting Period:
- 2019-04-12
- Accepted Time:
- 2019-04-16 21:28:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1646382 | Matthew Rabinowitz | C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-13 | 1,227 | $0.00 | 1,284,408 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-04-15 | 614 | $20.25 | 1,283,794 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2019-04-12 | 220,000 | $0.00 | 220,000 | $20.27 |
Common Stock | Restricted Stock Units | Acquisiton | 2019-04-12 | 6,403 | $0.00 | 6,403 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2019-04-13 | 1,227 | $0.00 | 1,227 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
220,000 | 2029-04-11 | No | 4 | A | Direct | |
6,403 | No | 4 | A | Direct | ||
3,683 | No | 4 | M | Direct |
Footnotes
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting April 13, 2019.
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer.
- The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
- The option shares vest over four years. 25% of the option shares vest and become exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
- The RSUs vest over four years. 25% of the RSUs vest on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
- The RSUs vest over four years. 25% of the RSUs vest on April 13, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter.